NSF provides $150,000 for device to assist blind and visually impaired

NewsGuard 100/100 Score

The National Science Foundation is providing $150,000 for a device developed by a Magnolia-based company with input from University of Arkansas at Little Rock experts and facilities.

FauxSee Innovations is working with UALR students and faculty to create Roboglasses,™ a device to assist the blind and visually impaired by dramatically reducing their chances for receiving head and upper-body injuries including protecting those around them.

The six-month, phase one award, stems from the technological contributions of Dr. Hirak Patangia and graduate students in UALR's Department of Engineering Technology.

Studies have shown that over 46 percent of the 11.4 million blind or visually impaired Americans experience head injuries at least once a month, with 23 percent of those injuries requiring medical attention.

More than 160 million people who are blind or visually impaired could benefit from using Roboglasses in conjunction with traditional methods, such as guide dogs, which cannot protect the user from upper body hazards, according to company co-founders Brandon Foshee and Tim Zigler.

UALR's Small Business and Technology Development Center's innovation consultant, Rebecca Norman and Dr. William H. Jacobson, professor and department chair of UALR's Counseling, Adult and Rehabilitation Education, also provided expertise in orientation and mobility for the product.

UALR faculty will work closely with the clients at World Services for the Blind to test the device if phase two of the award is funded, according to Jacobson.

Source: The National Science Foundation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New tARC-seq method enhances precision in tracking SARS-CoV-2 mutations